Cargando…
IL-27/IL-27RA signaling may modulate inflammation and progression of benign prostatic hyperplasia via suppressing the LPS/TLR4 pathway
BACKGROUND: Benign prostatic hyperplasia (BPH) is the most common urologic disease affecting aging men. The pathogenesis of BPH is multi-factorial, and chronic inflammation (CI) might be the central mechanism. Interleukin (IL)-27 signaling has been suggested as a modulator in autoimmune and inflamma...
Autores principales: | Lo, Hua-Cheng, Yu, Dah-Shyong, Gao, Hong-Wei, Tsai, Mong-Hsun, Chuang, Eric Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798123/ https://www.ncbi.nlm.nih.gov/pubmed/35117826 http://dx.doi.org/10.21037/tcr-20-1509 |
Ejemplares similares
-
Association of IL10, IL10RA, and IL10RB Polymorphisms with Benign Prostate Hyperplasia in Korean Population
por: Yoo, Koo Han, et al.
Publicado: (2011) -
Expression of Heat Shock Protein 27 in Benign Prostatic Hyperplasia with Chronic Inflammation
por: Jiang, Yuqing, et al.
Publicado: (2015) -
Associations of IL-27 Polymorphisms and Serum IL-27p28 Levels With Osteosarcoma Risk
por: Tang, Yu-jin, et al.
Publicado: (2014) -
Expression Levels of IL-17A, IL-17F, IL-17RA, and IL-17RC in Prostate Cancer with Taking into Account the Histological Grade according to Gleason Scale in Comparison to Benign Prostatic Hyperplasia: In Search of New Therapeutic Options
por: Janiczek, Marlena, et al.
Publicado: (2020) -
Identification of Interleukin-27 (IL-27)/IL-27 Receptor Subunit Alpha as a Critical Immune Axis for In Vivo HIV Control
por: Ruiz-Riol, M., et al.
Publicado: (2017)